Jean‐Louis Hébert

9.8k total citations · 1 hit paper
144 papers, 4.8k citations indexed

About

Jean‐Louis Hébert is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jean‐Louis Hébert has authored 144 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cardiology and Cardiovascular Medicine, 32 papers in Immunology and Allergy and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jean‐Louis Hébert's work include Allergic Rhinitis and Sensitization (30 papers), Asthma and respiratory diseases (24 papers) and Cardiomyopathy and Myosin Studies (14 papers). Jean‐Louis Hébert is often cited by papers focused on Allergic Rhinitis and Sensitization (30 papers), Asthma and respiratory diseases (24 papers) and Cardiomyopathy and Myosin Studies (14 papers). Jean‐Louis Hébert collaborates with scholars based in France, Canada and Belgium. Jean‐Louis Hébert's co-authors include Yves Lecarpentier, D. S. Chemla, Marc Humbert, Jean Bousquet, Catherine Coirault, Alexandre Vallée, Karen Zamani, Martin Blogg, Jon G. Ayres and Raymond G. Slavin and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Jean‐Louis Hébert

138 papers receiving 4.6k citations

Hit Papers

Benefits of omalizumab as add‐on therapy in patients with... 2004 2026 2011 2018 2004 250 500 750

Peers

Jean‐Louis Hébert
Robin J. McAnulty United Kingdom
A. Magnan France
Robin N. Poston United Kingdom
Benjamin D. Medoff United States
S.T. Holgate United Kingdom
Jean‐Louis Hébert
Citations per year, relative to Jean‐Louis Hébert Jean‐Louis Hébert (= 1×) peers Marek Sanak

Countries citing papers authored by Jean‐Louis Hébert

Since Specialization
Citations

This map shows the geographic impact of Jean‐Louis Hébert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Louis Hébert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Louis Hébert more than expected).

Fields of papers citing papers by Jean‐Louis Hébert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Louis Hébert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Louis Hébert. The network helps show where Jean‐Louis Hébert may publish in the future.

Co-authorship network of co-authors of Jean‐Louis Hébert

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Louis Hébert. A scholar is included among the top collaborators of Jean‐Louis Hébert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Louis Hébert. Jean‐Louis Hébert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kouidri, Smaïne, et al.. (2024). On the prediction of the effect of bi-ventricular assistance after cardiac explantation on the vascular flow physiology: A numerical study. Journal of Applied Biomedicine. 44(1). 105–118. 1 indexed citations
2.
Bitker, Laurent, et al.. (2022). Time-Controlled Adaptive Ventilation Does Not Induce Hemodynamic Impairment in a Swine ARDS Model. Frontiers in Medicine. 9. 883950–883950. 3 indexed citations
3.
Hébert, Jean‐Louis, et al.. (2020). Pulsatility in ventricular assistance devices: A translational review focused on applied haemodynamics. Archives of cardiovascular diseases. 113(6-7). 461–472. 7 indexed citations
4.
Lecarpentier, Yves, Olivier Schussler, Jean‐Louis Hébert, & Alexandre Vallée. (2020). Molecular Mechanisms Underlying the Circadian Rhythm of Blood Pressure in Normotensive Subjects. Current Hypertension Reports. 22(7). 50–50. 17 indexed citations
5.
Maupain, Carole, Nicolas Badenco, Françoise Pousset, et al.. (2018). Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator. JACC. Clinical electrophysiology. 4(6). 757–768. 20 indexed citations
6.
Avard, Denise, et al.. (2013). Funding considerations for the disclosure of genetic incidental findings in biobank research. Clinical Genetics. 84(5). 397–406. 21 indexed citations
7.
Cicardi, Marco, Timothy Craig, I. Martinez‐Saguer, Jean‐Louis Hébert, & Hilary Longhurst. (2013). Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration. International Archives of Allergy and Immunology. 161(Suppl. 1). 3–9. 26 indexed citations
8.
Lecarpentier, Yves, Victor Claes, Édouard Lecarpentier, et al.. (2011). Comparative statistical mechanics of myosin molecular motors in rat heart, diaphragm and tracheal smooth muscle. Comptes Rendus Biologies. 334(10). 725–736. 6 indexed citations
9.
Humbert, Marc, Richard Beasley, Jon G. Ayres, et al.. (2004). Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 60(3). 309–316. 839 indexed citations breakdown →
10.
Chachques, Juan Carlos, G Fontaine, Jean‐Louis Hébert, et al.. (2003). Right ventricular cardiomyoplasty: 10-year follow-up. The Annals of Thoracic Surgery. 75(5). 1464–1468. 21 indexed citations
11.
Fontaine, G, Jean‐Louis Hébert, D. S. Chemla, et al.. (2001). La dysplasie ventriculaire droite. 7(5). 361–368.
12.
Boutin, Yvan, et al.. (1996). Characterization of Allergenic Determinants on the C-Terminal Region of the r-Lol p 1. Advances in experimental medicine and biology. 409. 425–429. 5 indexed citations
13.
Villeneuve, A, Laurent Brossay, Gilles Paradis, & Jean‐Louis Hébert. (1994). Determination of neutralizing epitopes in variable domains I and IV of the major outer-membrane protein from Chlamydia trachomatis serovar K. Microbiology. 140(9). 2481–2487. 9 indexed citations
14.
Dolovich, Jerry, William B. Chodirker, M. Drouin, et al.. (1990). Fluticasone propionate: a large multicentre trial. Respiratory Medicine. 84. 31–32. 14 indexed citations
15.
Carpio, Jaime Del, et al.. (1989). Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 84(5). 741–746. 52 indexed citations
16.
Hébert, Jean‐Louis, et al.. (1989). Percutaneous brachial approach for transluminal coronary angioplasty. Catheterization and Cardiovascular Diagnosis. 18(2). 118–120. 7 indexed citations
17.
Mourad, Walid, Salaheddine Mécheri, Gabriel Peltre, B. David, & Jean‐Louis Hébert. (1988). Study of the epitope structure of purified Dac G I and Lol p I, the major allergens of Dactylis glomerata and Lolium perenne pollens, using monoclonal antibodies.. The Journal of Immunology. 141(10). 3486–3491. 41 indexed citations
18.
Gutkowski, Andrzej, et al.. (1988). Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 81(5). 902–907. 36 indexed citations
19.
Fournier, Claude, et al.. (1985). [Hypertrophic myocardiopathy with isolated obstruction of the right ventricle].. PubMed. 34(2). 71–4. 5 indexed citations
20.
Hr, Schumacher, et al.. (1978). Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 91(3). 409–22. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026